12th International Conference on Reproductive Health, Embryology and Fertility: November 2026

Welcome Message

We are pleased to welcome participants from around the world to the 12th International Conference on Reproductive Health, Embryology and Fertility, taking place in Paris, France on March 18-19, 2027. The conference will be held under the theme “Advancing Reproductive Science, Transforming Fertility Care” highlighting the latest advancements in reproductive medicine, embryology, fertility care, and assisted reproductive technologies.

The conference provides a valuable platform to explore current developments and future directions in reproductive health and fertility research. We are honored to host distinguished speakers and leading experts who will share their knowledge, research findings, and practical insights, creating an enriching learning experience for all participants.

We eagerly anticipate welcoming you to the 12th International Conference on Reproductive Health, Embryology and Fertility and sharing this impactful virtual experience with you.

About the Conference :

The 12th International Conference on Reproductive Health, Embryology and Fertility is a premier global event dedicated to advancing the field of reproductive medicine, embryology, and fertility care. Scheduled for March 18-19, 2027, in Paris, France, it provides an exceptional platform for reproductive health specialists, embryologists, fertility experts, clinicians, researchers, academicians, and industry professionals to come together and discuss the latest developments in reproductive science.

The conference theme, “Advancing Reproductive Science, Transforming Fertility Care” encompasses a wide range of topics including assisted reproductive technologies, embryology, fertility preservation, reproductive genetics, maternal and reproductive health, and emerging innovations in fertility care. Over two days, attendees will participate in keynote presentations, interactive panels, hands-on workshops, and poster sessions, while also exploring an exhibition of the latest products, technologies, and advancements in reproductive medicine.

Set against the inspiring backdrop of France, the conference combines professional learning with opportunities for collaboration, networking, and engagement with industry leaders, ensuring participants leave with new knowledge, valuable connections, and innovative strategies to advance reproductive health and fertility care.

Why to Attend ?

Beyond the scientific program the conference provides valuable opportunities to network with reproductive health specialists embryologists gynecologists fertility experts researchers educators and industry leaders from around the world. Participants can discover emerging technologies exchange ideas build meaningful collaborations and stay updated with the latest innovations shaping the future of reproductive health and fertility care.

The 12th International Conference on Reproductive Health, Embryology and Fertility, taking place on March 18-19, 2027, in Paris, France, offers an excellent platform for reproductive health professionals to explore the latest advancements in reproductive medicine embryology and fertility care. Attendees will gain insights into assisted reproductive technologies fertility preservation reproductive genetics embryo culture fertility diagnostics and maternal health through evidence-based sessions presented by leading international experts.

Target Audience

Reproductive Health Specialists
Embryologists
Obstetricians and Gynecologists (OB/GYNs)
Reproductive Endocrinologists
IVF Specialists
Andrologists
Clinical Embryologists
Reproductive Genetics Specialists
Maternal and Fetal Medicine Specialists
Women's Health Professionals
Fertility Nurses
Assisted Reproductive Technology (ART) Professionals
Clinical Researchers
Academic Researchers and Educators
Laboratory Scientists
Healthcare Professionals
Pharmaceutical Industry Professionals
Medical Device and Biotechnology Companies

Sessions and Tracks :

Market Analysis :

The global reproductive health and fertility market is growing steadily, projected to increase from $38 billion in 2024 to approximately $68 billion by 2033. This growth is driven by rising infertility rates, delayed parenthood, increasing awareness of reproductive health, and growing demand for assisted reproductive technologies (ART). Advancements in embryology, fertility preservation, reproductive genetics, and fertility treatments continue to support market expansion worldwide.

Technological innovations such as AI-assisted embryo selection, advanced genetic testing, and improved cryopreservation techniques are enhancing treatment success and accessibility. Increasing investments in fertility clinics and reproductive healthcare services are further driving market growth. The following graphs illustrate the market growth over time and the key factors contributing to this upward trend.

Global Reproductive Health and Fertility Market Growth (2024–2033)

This line graph shows the steady increase in the global reproductive health and fertility market from $38 billion in 2024 to approximately $68 billion by 2033. The growth reflects increasing demand for fertility treatments, reproductive healthcare services, and advanced assisted reproductive technologies worldwide.

Key Factors Driving the Reproductive Health and Fertility Market

This bar graph illustrates the major factors contributing to the growth of the reproductive health and fertility market. Rising infertility rates account for the largest share followed by delayed parenthood increasing awareness of reproductive health and advancements in assisted reproductive technologies.

Menu